GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Kagazil Gushakar
Country: Saint Kitts and Nevis
Language: English (Spanish)
Genre: Music
Published (Last): 26 February 2005
Pages: 163
PDF File Size: 17.44 Mb
ePub File Size: 8.71 Mb
ISBN: 321-1-45008-374-4
Downloads: 87870
Price: Free* [*Free Regsitration Required]
Uploader: Mojora

The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Glycopyrronium. Sufentanil The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Sufentanil. Isoxsuprine The risk or severity of Tachycardia can be increased when Glycopyrroate is combined with Isoxsuprine.

Potassium Guaiacolsulfonate The therapeutic efficacy of Potassium Guaiacolsulfonate can be decreased when used in combination with Glycopyrronium. Romifidine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Romifidine. Cocaine The risk or severity of adverse effects can be increased glcopyrrolate Cocaine is combined with Glycopyrronium. The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Glycopyrronium.

Ginkgo biloba The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ginkgo biloba. Metamfetamine The glycopyrrrolate or severity of Tachycardia can be increased when Glycopyrronium is combined with Metamfetamine. Rilmenidine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Rilmenidine.

How many drug targets are there? Propiomazine The risk or severity of adverse msdss can be increased when Propiomazine is combined with Glycopyrronium. Tacrine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Tacrine. Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Glycopyrronium. Fenpiverinium The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Glycopyrronium.

  ALISTAIR MACLEAN SANTORINI PDF

Botulinum toxin type A The risk or severity of adverse effects can be increased when Tlycopyrrolate is combined with Botulinum Toxin Type A. Mecamylamine Mecamylamine may increase the anticholinergic activities of Glycopyrronium. Puromycin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Puromycin. The risk or severity of adverse effects can be increased when Aripiprazole is glycopyrrolaet with Glycopyrronium.

The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Dezocine. GW The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with GW Fenoterol Mses may increase the anticholinergic activities of Fenoterol. Metocurine The risk or severity of adverse effects can be increased when Metocurine is combined with Glycopyrronium.

Glycopyrronium

The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Desvenlafaxine. Clonidine Mssd risk or severity of Tachycardia can be increased when Clonidine is combined with Glycopyrronium. Sulpiride Glycopyrronium may increase the anticholinergic activities of Sulpiride.

Glycopyrronium – DrugBank

Xamoterol The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Xamoterol. Tegaserod The therapeutic efficacy of Tegaserod can be decreased when used in combination with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with 4-Bromo-2,5-dimethoxyamphetamine. The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Glycopyrronium.

Plantago ovata seed The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Glycopyrronium.

Procaine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Procaine. The risk or severity of adverse effects can be increased when Pancuronium is combined with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ephedra.

  ASERTYWNOSC I SZTUKA CELNEJ RIPOSTY PDF

The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with 1,Phenanthroline. The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Glycopyrronium. Epinephrine The risk or severity of Tachycardia can be increased when Epinephrine is combined with Glycopyrronium.

The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Olanzapine is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Dicyclomine is combined with Glycopyrronium. Dosulepin The risk or severity of adverse effects can be increased when Dosulepin is combined with Glycopyrronium. Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Glycopyrronium.

Benzilone The risk glycoyrrolate severity of adverse effects can be increased when Benzilone is combined with Glycopyrronium.

Midomafetamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Midomafetamine. Phenazocine The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Phenazocine.

The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Oxymorphone. The risk or severity of Tachycardia can be increased when Clonidine is combined with Glycopyrronium. The serum concentration of Methyclothiazide can be increased when it is combined with Glycopyrronium.

Glycopyrronium Targets 3 Biointeractions 3. Alfentanil The risk or severity of adverse effects can be increased when Glycopyrronium is combined glyxopyrrolate Alfentanil.

The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Lofexidine.